Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway
|更新时间:2024-03-14
|
Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway
“The latest research has found that Qizhu Formula can improve liver lipid metabolism, reduce oxidative stress, and promote liver cell repair in non-alcoholic fatty liver disease mice by activating the AMPK signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 8, Pages: 49-56(2024)
ZHANG Qiuyi,ZHOU Zhenhua.Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(08):49-56.
ZHANG Qiuyi,ZHOU Zhenhua.Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(08):49-56. DOI: 10.13422/j.cnki.syfjx.20232237.
Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway